The Disease-related Compounds Screen library is a collection of active compounds that have been screened and validated against specific disease targets. These compounds have been proven by scientific studies to effectively bind to disease-related biomarkers, such as specific receptors, enzymes, or other key proteins, thereby intervening or modulating the biological process of the disease. The compounds in the library are not only essential for understanding the molecular mechanisms of disease, but also play a central role in the discovery and development process of new drugs. With these compounds, researchers are able to rapidly identify potential therapeutic candidates in the early stages of drug development and further perform pharmacological and safety assessments. The disease-related compound screening library has a wide range of applications, covering fields ranging from cancer to neurodegenerative diseases to cardiovascular diseases, providing researchers with a powerful tool to explore and validate novel therapeutic approaches. As science and technology continue to advance, these repositories will continue to play an important role in advancing medical research and improving patient outcomes.
